TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
Go back to TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial| (NASDAQ: TMDX) | Delayed: 81.07 +0.79 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.28 | 52 Week High | $ | |||
| Open | $80.96 | 52 Week Low | $ | |||
| Day High | $83.90 | P/E | N/A | |||
| Day Low | $80.56 | EPS | $ | |||
| Volume | 962,659 | |||||



